Every Patient. Every Dollar. Protected.
Stop Copay Maximizer Leakage Before It Happens
RIS Rx helps pharmaceutical manufacturers identify and prevent copay maximizer and accumulator exposure in real time—protecting patient affordability programs and gross-to-net performance.
The Problem
More employers and payers are implementing copay maximizer programs that fundamentally
change how manufacturer copay support is used.
The result:
RIS Rx was built to solve this problem.
- Copay assistance is exhausted prematurely
- Patients experience affordability confusion at the pharmacy
- GTN costs increase without improved adherence
- Manufacturers lose visibility into maximizer plan exposure
Why Copay Vendors Miss It
Traditional copay vendors often miss GTN leakage because their infrastructure was built to process claims and distribute funds, not to monitor how those funds interact with today’s increasingly complex payer dynamics.
#1 - They focus on transaction processing - not net revenue integrity.
#2 - They have limited visibility into Maximizer & Accumulator Programs.
#3 - Data is siloed across PBMs and plans, making it difficult to detect.
#4 - Legacy copay programs are built to react to claims, not built for predictive detection.
Copay vendors are optimized for administration, not revenue protection. In today’s environment — shaped by maximizers, accumulators, and complex PBM economics — that gap in visibility and analytics is where GTN leakage often hides.
Our Proven Impact
3M+
patients supported
$1B+
revenue protected
35K+
transactions tracked daily
150+
unique drug brands tracked
Our Maximizer Product: Benefit Patient Solution (BPS)
PBM / Payer-based leakage solution
Benefit Patient Solution
Addresses maximizer and accumulator GTN leakage in real-time.
Real-time GTN Revenue Protection for your leading drug brands.
How it Works
Purchase only the products that you need.
Pay based on the dollars you save.
Get support any time from your dedicated, in-house team of experts.
RIS Rx is trusted by the world’s leading pharmaceutical manufacturers.
"We expected addressing GTN leakage to be a cost center. Instead, it became a source of profitability."
- Pharma CFO
"RIS Rx's eBV technology is special and I don't need to micromanage them. They are always on it and always get right back to me."
— Director Vendor Management, Patient Support
"RIS Rx's customer service is outstanding. Their team always made time for us. I would re-implement using them."
— Director of Patient Access
"RIS Rx's flexibility and technology are great. They resolved issues with our prior vendor."
— VP of Commercial Operations
Uncover Your Maximizer Exposure
Most manufacturers cannot see their true maximizer exposure until it has already impacted
copay spend.
RIS Rx helps identify maximizer plans, quantify GTN risk, and protect patient affordability
programs in real time.
Give us 30 minutes and discover how much maximizer exposure may be impacting your
brand.
"We expected addressing GTN leakage to be a cost center. Instead, it became a source of profitability."
- Pharma CFO
20+
of the world's leading pharmaceutical manufacturers trust RIS Rx
150+
leading drug brands across all therapeutic areas
100
Net Promoter Score
RIS Rx offers real-time GTN Revenue Protection to the world's leading pharmaceutical manufacturers, ensuring that every dollar allocated for affordability reaches the right patient at the right time.
Copay Maximizer Programs Are Expanding Rapidly
The RIS Rx Approach
Identify Maximizer Plans Before They Impact Your Program
RIS Rx provides real-time maximizer leakage prevention, allowing manufacturers to detect
when patients are enrolled in maximizer insurance plans before the leakage occurs.
Our pharmacist-led platform helps teams:
- - Identify maximizer plans and PBM behavior in real time
- - Quantify maximizer-driven GTN exposure
- - Ensure copay assistance reaches the patients it was intended for
Without clear visibility, manufacturers often discover maximizer exposure months after it has already impacted GTN performance.
Instead of discovering maximizers months later in a retrospective report, RIS Rx provides visibility at the moment of patient enrollment.
RIS Rx’s Benefit Patient Solution (BPS) identifies patients enrolled in copay maximizer and accumulator plans in real time—giving manufacturers immediate visibility into maximizer-driven GTN exposure.
By analyzing patient benefit design at enrollment, BPS helps manufacturers:
- Identify maximizer insurance plans before first fill
- Quantify maximizer-driven GTN exposure
- Ensure copay assistance reaches the patients it was intended for
Instead of discovering maximizer impact months later, BPS delivers real-time visibility and protection for your copay programs.